Tekla Life Sciences Investors

Location

Massachusetts

Founded

2000-01-26

Website

https://www.teklacap.com

Risk Signals

155 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Stock Market Events (128) Investment Strategies (101) Equity Analysis & Ratings (42) Acquisition Announcements (36) Earnings Reports & Warnings (36) Issuing Shares (34) Stock Buyback (34) Financial Reporting (18) Corporate Deals (18) Inter-Organizational Collaborations (17) Regulatory Updates (17) Asset Divestment (16) Shareholders Feedback (15) Offshore Tax Practices (14) Capital Funding Requests (7) Funding Announcements (6) Business Growth Initiatives (5) Corporate Governance Policies (4) Workforce Reductions (2) Corporate Restructuring (2) Credit Rating Updates (2) Illicit Financial Practices (2) Initial Public Offering Launch (2) New Product Release (2) Access and Affordability Initiatives (2) Legal and Regulatory Management (1) Corporate Rebranding (1) Competitive Market Dynamics (1) Climate Change Effects (1) Material Supply Trends (1)

Recent Articles about Tekla Life Sciences Investors

Live alerts from global media, monitored by Business Radar

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

2023-06-30 (nasdaq.com)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under

Read more
Tekla Capital Management LLC Announces Closing of Transaction With abrdn

2023-06-30 (nasdaq.com)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under

Read more
Tekla Life Sciences Investors Paid Distribution | Tekla Capital ...

2016-08-06 (teklacap.com)

Tekla Life Sciences Investors Paid Distribution | Tekla Capital ...

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’ s

Read more
Tekla Capital Management LLC Announces Closing of Transaction With abrdn

(morningstar.com)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Tekla Capital Management LLC( Tekla) announced today that it has completed the sale of its advisory

Read more
Tekla Capital Management LLC Announces Closing of Transaction With abrdn

(morningstar.com)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Tekla Capital Management LLC( Tekla) announced today that it has completed the sale of its advisory

Read more

Never miss a headline about Tekla Life Sciences Investors

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages